ISAR-LEFT MAIN 2 Trial: Zotarolimus- versus Everolimus- Eluting Stents for Treatment of Unprotected Left Main Coronary Artery Lesions
2013 ◽
Vol 111
(7)
◽
pp. 41B
◽
Keyword(s):
2010 ◽
Vol 55
(10)
◽
pp. A182.E1706
2007 ◽
Vol 60
(8)
◽
pp. 811-816
Keyword(s):
2014 ◽
Vol 64
(11)
◽
pp. B68
2013 ◽
Vol 167
(2)
◽
pp. 613-617
◽